Coromandel International growth ratios

Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+30.7%+9.2%−25.5%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+22.4%+9.6%−18.0%
+14.7%+7.7%−20.9%
−7.2%+24.6%−18.5%
−5.4%+25.8%−18.5%
+29.5%+19.4%+11.4%
+17.0%+18.8%+19.5%
+60.6%−28.6%−15.9%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

COROMANDEL₹1,711.00

Coromandel International Ltd.

· Chemicals
₹ CrorePeersCHAMBLFERTDEEPAKFERTGSFCUPLPIINDSRFSOLARINDSPIDILITINDMcap ₹50,475 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue Growth—-25.5+9.2+30.7—
EBITDA Growth—-18.0+9.6+22.4—
EBIT Growth—-20.9+7.7+14.7—
Net Income Growth—-18.5+24.6-7.2—
EPS Growth—-18.5+25.8-5.4—
Total Assets Growth—+11.4+19.4+29.5—
Total Equity Growth—+19.5+18.8+17.0—
Cash from Operations Growth—-15.9-28.6+60.6—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.